Background {#Sec1}
==========

Placenta accreta is associated with multiple adverse outcomes, including massive haemorrhage, cesarean hysterectomy, and maternal mortality \[[@CR1]--[@CR5]\]. Pregnant women presenting with placenta previa and prior cesarean have a higher risk of placenta accreta \[[@CR6]\]. In recent decades, the prevalence of placenta previa-accreta has increased \[[@CR7]\], partly due to increasing rates of cesarean births \[[@CR8]\].

The complications of placenta previa-accreta can be life-threatening, thus, pre-operative prediction of these adverse outcomes is of great importance \[[@CR9], [@CR10]\]. Several articles have provided models to predict placental invasion \[[@CR11]--[@CR13]\] in cases with placenta previa and prior cesarean. However, there currently are no models to predict adverse clinical outcomes in these patients.

Therefore, the purpose of the present study is to analyze related risk factors of adverse outcomes, including blood loss and hysterectomy, in pregnancies complicated with placenta previa and prior cesarean. A pre-surgical prediction system will be generated using risk factors that are associated with hysterectomy and blood loss.

Materials and methods {#Sec2}
=====================

The present study is a retrospective analysis of risk factors relating to hysterectomy and blood loss during surgery in suspected cases of placenta previa-accreta. Clinical data was obtained from the medical history system at the First Affiliated Hospital of Sun Yat-sen University from February 2003 to December 2016. All cases with a final diagnosis of "placenta previa/low lying placenta (ICD:O44.001-105)" and "scarred uterus complicated with pregnancy (ICD: O34.200-202)" were collected for primary analysis. This study was approved by the ethical committees of The First Affiliated Hospital of Sun Yat-sen University (2017--323).

Medical records were reviewed and clinical, laboratory, and ultrasonic information was collected. Clinical and laboratory information included maternal age, gestational age at delivery, time elapsed since last cesarean, number of prior cesareans, prior curettage, pregravid and prepartum BMI, neonatal birth weight, Apgar scores, and results of last hemoglobulin test prior to delivery. Ultrasonic information included four major signs related to placenta invasion (vascular lacunae, loss of normal hypoechoic retroplacental zone, retroplacental myometrial thinness, and placental thickness), as well as type of placenta previa (central, partial, marginal or low-lying) and placenta position (anterior, posterior or sidewall).

Hysterectomy was taken as the primary outcome and blood loss as the secondary outcome. The relationship between clinical, laboratory, and ultrasonic information and adverse outcomes were analyzed. Continuous and normally distributed variables were analyzed by independent sample *t* test. Categorical variables were examined with Chi-square test. Related factors with statistical significance were further scrutinized using linear logistic regression.

By applying all significant factors related to hysterectomy, we generated an evaluation system referred to as "Hysterectomy Index in Placenta Previa with Prior cesarean (HIPs)". Each related factor was weighted to create a scale and the sensitivity and specificity were calculated for each score.

Results {#Sec3}
=======

Reviewing the database, 263 pregnant women met the inclusion criteria: diagnosis of both placenta previa and scarred uterus. Of all cases, 41 were excluded because their uterine scars were due to reasons other than previous cesarean (i.e. myomectomy), one was excluded because the patient did not deliver in our hospital, and two were excluded because ultrasonic data were not obtained due to emergency surgery. Of the remaining 219 cases in the final analysis, 25 received surgical hysterectomy (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Process of clinical data collection and selection

Basal maternal and neonatal information for hysterectomy and control cases are shown in Table [1](#Tab1){ref-type="table"}. There were no statistically significant differences in age, gestational age, time since last surgery, prevalence of GDM or hypertensive disorder, bleeding history prior to delivery, pregravid and prepartum BMI, neonatal birthweight and Apgar scores. The hysterectomy group had higher incidence of two or more prior cesarean deliveries (20.0% vs 7.2%, *P* = 0.049), as well as lower hemoglobulin levels prior to delivery (103.04 ± 10.94 g/L vs 114.12 ± 15.08 g/L, *P* \< 0.001). The hysterectomy group also had a higher incidence of prior curettage but did not reach statistical significance (68.0% vs 46.4%, *P* = 0.055). Table 1Basal characteristics of research populationHysterectomyControl*P* valueNumber25194*Demographic characteristics and medical history* Age (Year)34.08 ± 4.4233.82 ± 4.130.773 Gestational age (Day)242.44 ± 31.53249.01 ± 34.740.371 Time since last surgery (Month)55.52 ± 29.7465.46 ± 37.640.205 Gestational diabetes mellitus (%)3(12)38(19.6)0.585 Hypertensive disorder (%)0(0)7(3.6)1.000 Prior Cesarean \> = 2 times (%)5(20.0)14(7.2)0.049 Prior curettage (%)17 (68.0)90(46.4)0.055 Bleeding prior to delivery (%)10(40.0)57(29.4)0.356*Physical and laboratory examinations* Pregravid BMI (kg/m^2^)21.83 ± 2.6621.91 ± 2.850.911 Prepartum BMI (kg/m^2^)26.09 ± 3.5026.30 ± 2.900.739 Last Hb before delivery (g/L)103.04 ± 10.94114.12 ± 15.08\< 0.001*Neonatal information* Birth weight (kg)2.45 ± 0.622.78 ± 0.800.057 Apgar 1 min9.23 ± 0.929.40 ± 1.510.599 Apgar 5 min9.77 ± 0.619.74 ± 1.180.899 Apgar 10 min9.82 ± 0.509.80 ± 1.140.931*Hb* Hemoglobulin*BMI* Body Mass Index

Since ultrasonic examination plays an important role in the prediction of surgery risks, we analyzed the characteristics of ultrasound images in detail. As shown in Table [2](#Tab2){ref-type="table"}, four signs indicating placenta invasion including vascular lacunae, loss of normal hypoechoic retroplacental zone, retroplacental myometrial thinness, and placental thickness, were all more prevalent in cases with hysterectomy. In addition, the incidence of central placenta previa and anterior placenta previa were higher in patients that received hysterectomy. Table 2Ultrasonic signs related to hysterectomy and blood loss in surgeryHysterectomyControl*P* valueNumber25194Vascular lacunae (%)17(68)16(8.2)\< 0.001Loss of normal hypoechoic retroplacental zone (%)22(88)9(4.6)\< 0.001Retroplacental myometrial thinness (%)4(16)5(2.6)0.011Placental thickness (%)12(48)8(4.1)\< 0.001Central Placenta previa (%)22(88)56(28.9)\< 0.001Anterior Placenta previa (%)25(100)102(54.8)\< 0.001

In the hysterectomy group, placenta adherence was observed in all cases with gross pathological examination, and 23 of them were further confirmed by microscopic pathology. In the 2 cases without description of placenta adherence in microscopic pathologic records, the gross manifestation of placenta adherence was obvious. One potential reason for the lack of microscopic pathology manifestation of these 2 cases may be inadequate selection of tissue from the uterus for microscopic examination.

To screen for risk factors that were associated with hysterectomy in these cases, we used logistic regression to analyze each clinical, laboratory, and ultrasonic parameter that was different in each group. As shown in Table [3](#Tab3){ref-type="table"}, linear logistic regression demonstrated that ultrasonic indication of central placenta previa, vascular lacunae, and loss of normal hypoechoic retroplacental zone were associated with hysterectomy. Table 3Predictors of hysterectomy in pregnant women complicated with placenta previa and prior cesareanRegression coefficientOR(95%CI)*P* valueVascular lacunae2.0417.701 (1.445, 41.051)0.017Central placenta previa2.43611.429 (1.395,93.618)0.023Loss of normal hypoechoic retroplacental zone3.47332.246 (5.886, 176.642)\< 0.001Input variables include: number of cesarean\> 1, prior curettage, last Hb before delivery, ultrasonic sign of vascular lacunae, loss of normal hypoechoic retroplacental zone, retroplacental myometrial thinness, placental thickness, central placenta previa, and anterior placenta previa

Next, we generated an 8-point scale to predict the probability of hysterectomy in pernicious placenta previa cases, termed the "Hysterectomy Index in Placenta Previa with Prior cesarean (HIPs)" score (Table [4](#Tab4){ref-type="table"}). The probability of hysterectomy for each HIPs score is shown in Table [5](#Tab5){ref-type="table"}, with the greatest area under the receiver operating characteristic curve of HIPs at 0.972 (Fig. [2](#Fig2){ref-type="fig"}). Table 4Hysterectomy Index in Placenta Previa with Prior cesarean (HIPs)ScoreVascular lacunae2Central placenta previa2.5Loss of normal hypoechoic retroplacental zone3.5 Table 5Probability of hysterectomy, and sensitivity, specificity, positive and negative predictive values of HIPs scoresHIPs ScoreNHysterectomy (%)Probability of Hysterectomy (%)Sensitivity (%)Specificity (%)PPV (%)NPV (%)\> = 230(0)1.86710068.629.1100\> = 2.5401(2.5)3.09310070.130.0100\> = 3.520(0)8.2439690.255.899.4\> = 4.5122(16.7)20.1849691.258.599.4\> = 5.533(100)41.5858896.475.998.4\> = 6117(63.6)54.4307696.473.196.9=81512(80.0)90.4454898.580.093.6*PPV* positive predictive value*NPV* negative predictive value Fig. 2Receiver operator curves of Hysterectomy Index in Placenta Previa with Prior cesarean (HIPs). The AUC of HIPs on prediction of hysterectomy in indicative cases was 0.972(95% CI: 0.949--0.994)

In the present study, there was no loss of life, therefore risk factors associated with maternal mortality was not studied. However, blood loss during surgery is an important risk factor of maternal mortality, also related to the decision of hysterectomy. Therefore, we studied risk factors that related to massive blood loss (more than 1000 ml during surgery). We found that ultrasonic indication of loss of normal hypoechoic retroplacental zone, placenta thickness, and central placenta previa were related to blood loss during surgery (Table [6](#Tab6){ref-type="table"}). Table 6Risk factors associated with massive blood loss in pregnant women complicated with placenta previa and prior cesarean\> = 1000 mL\< 1000 mL*P* ValueAdjusted OR (95%CI)Adjusted *P* value*N*48171Age (Years)34.10 ± 4.0033.78 ± 4.200.638Gestational age (Days)249.8 ± 22.9247.8 ± 36.90.726Time since last surgery (Months)58.1 ± 33.366.1 ± 37.80.188Gestational diabetes mellitus (%)11(22.9)30(17.5)0.407Hypertensive disorder (%)07(4.1)0.352Prior Cesarean \> = 2 times (%)10(20.8)9(5.3)0.002Prior curettage (%)29(60.4)78(45.6)0.075Bleeding prior to delivery (%)19(39.6)48(28.1)0.156Pregravid BMI (kg/m^2^)22.20 ± 2.7021.80 ± 2.860.403Prepartum BMI (kg/m^2^)26.42 ± 3.1326.24 ± 2.920.711Last Hb before delivery (g/L)106.60 ± 13.17114.61 ± 15.130.001Vascular lacunae24(50.0)9(5.3)\< 0.001Loss of normal hypoechoic retroplacental zone29(60.4)2(1.2)\< 0.001115.933 (11.913,1128.228)\< 0.001Retroplacental myometrial thinness6(12.5)3(1.8)0.004Placental thickness19(39.6)1(0.6)\< 0.00177.542 (4.394,1368.455)0.003Central Placenta previa36(75.0)42(24.6)\< 0.0013.563 (1.287,9.861)\< 0.001Anterior Placenta position39(81.3)88(54.0)0.001Input parameters in logistic regression were: Prior Cesarean \> = 2 times, Last Hb before delivery, vascular lacunae, loss of normal hypoechoic retroplacental zone, placental thickness, central placenta previa, anterior placenta position

Discussion {#Sec4}
==========

The main challenge to clinical obstetricians on management of placenta previa-accreta is that more than half of the cases were not diagnosed prior to cesarean \[[@CR14], [@CR15]\]. Low pre-operative diagnosis rates can lead to increased blood loss, cesarean hysterectomy, and maternal mortality. In the present study, we analyzed related factors of cesarean hysterectomy and blood loss in suspected cases of placenta previa-accreta, and developed a predictive system termed "Hysterectomy Index in Placenta Previa with Prior cesarean (HIPs)".

The application of HIPs can pre-operatively predict risk of cesarean hysterectomy in suspected cases, with a receiver operator curve of 0.972. Three parameters, including ultrasonic image of central placenta previa, vascular lacunae, and loss of normal hypoechoic retroplacental zone, were screened to form the HIPs point system with a total score of 8. For example, a pregnant woman with ultrasonic finding of central placenta previa and loss of normal hypoechoic retroplacental zone would receive a total score of 6, and the predicted incidence of hysterectomy would be 54.430%.

By using the HIPs score, cases with high risk of hysterectomy may be identified prior to operation, allowing additional time for full pre-surgical preparation, including ureteral stent insertion \[[@CR16]\], verifying sufficient blood bank supplies, and arrangements for multidisciplinary therapy. In addition, patients with high risk of hysterectomy may be informed prior to surgery, which will reduce the risk of medical dispute.

In the HIPs system, ultrasonic evaluation of placental invasion plays a very important role. Ultrasonic signs indicating placental invasion, such as vascular lacunae and loss of normal hypoechoic retroplacental zone \[[@CR12], [@CR17]\], were included in the HIPs scoring system. This finding is consistent with previous reports on risk of placenta accreta \[[@CR12]\]. In addition, loss of normal hypoechoic retroplacental zone and placenta thickness, other placental invasion signs, were related to massive blood loss in the present study. In a study by Yosuke Baba et al, ultrasound signs of lacunae was associated with allogeneic blood transfusion in cesarean section for placenta previa \[[@CR18]\]. Jung-Won Kim et al found that ultrasonic signs of invasion was associated with massive transfusion in placenta previa cases \[[@CR19]\]. These findings indicate that placenta accreta is the major cause of adverse outcomes in these cases.

There are several limitations of the present study. First, this is a retrospective study, so the predictive power of HIPs should be confirmed by a prospective study. Second, placental invasion was not confirmed in all cases, since only 25 patients received hysterectomy. A previous study \[[@CR12]\] only included cases with histologic confirmation, so the information of those suspected patients was lost. In the present study, we focused on hysterectomy, a confirmed clinical outcome, rather than placental invasion in the whole cohort.

Despite these limitations, the present study developed a predictive system of cesarean hysterectomy in suspected cases of placenta previa-accreta, based on a full review of risk factors in a cohort spanning 10 years. To the best of our knowledge, this is the first analysis focused on adverse clinical results, including cesarean hysterectomy and massive blood loss in pregnant women complicated with both placenta previa and prior cesarean.

Conclusion {#Sec5}
==========

In conclusion, the HIPs index may help clinical doctors identify high risk cases, so that more precise counseling and full preparation for delivery can be made to improve clinical outcomes. The predictive value of HIPs may be examined in subsequent prospective observations.
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